Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 3/20 | 0.34 |
| ▸ | YWHAG | P61981 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | IDE | P14735 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384829 | 1.00 | LMNA (0.35) | LMNANPC1RAB9ARXFP1APP | |
| SCHEMBL29512642 | 0.94 | TLR8 (0.34) | LMNANPC1RAB9ARXFP1MAPT | |
| SCHEMBL2775132 | 0.94 | TLR8 (0.34) | LMNANPC1RAB9ARXFP1MAPT | |
| SCHEMBL1733769 | 0.92 | MAPK1 (0.35) | LMNANPC1RAB9ARXFP1MAPT | |
| SCHEMBL30039355 | 0.90 | LMNA (0.36) | LMNANPC1RAB9AAPPYWHAG | |
| SCHEMBL7268063 | 0.89 | NPC1 (0.46) | LMNANPC1RAB9AAPPYWHAG | |
| SCHEMBL29358846 | 0.88 | NPC1 (0.47) | LMNANPC1RAB9AAPPYWHAG | |
| SCHEMBL93485 | 0.88 | NPC1 (0.47) | LMNANPC1RAB9AAPPYWHAG | |
| SCHEMBL29384278 | 0.87 | MAPT (0.36) | LMNANPC1RAB9AAPPYWHAG | |
| SCHEMBL106982 | 0.87 | MAPT (0.36) | LMNANPC1RAB9AAPPYWHAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 409 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3173826-B1 | HYDROGEL COMPOSITION AND HYDROGEL CONTACT LENSES MADE OF THE COMPOSITION | PEGAVISION CORP (TW) | 2019-02-13 | — | — | EP | claimed |
| EP-3173826-A1 | HYDROGEL COMPOSITION AND HYDROGEL CONTACT LENSES MADE OF THE COMPOSITION | Pegavision Corporation (TW) | 2017-05-31 | — | — | EP | claimed |
| US-9482788-B2 | UV-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | PEGAVISION CORPORATION (TW) | 2016-11-01 | — | — | US | claimed |
| US-20160161638-A1 | UV-BLOCKING SILICONE HYDROGEL COMPOSITION AND SILICONE HYDROGEL CONTACT LENS CONTAINING THEREOF | PEGAVISION CORPORATION (TW) | 2016-06-09 | — | — | US | claimed |
| EP-3029081-A1 | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof | Pegavision Corporation (TW) | 2016-06-08 | — | — | EP | claimed |
| US-7584630-B2 | Photochromic ocular devices | TRANSITIONS OPTICAL, INC. (US) | 2009-09-08 | — | — | US | claimed |
| EP-1604231-B9 | PHOTOCHROMIC OCULAR DEVICES | TRANSITIONS OPTICAL INC (US) | 2009-01-07 | — | — | EP | claimed |
| EP-1604231-B1 | PHOTOCHROMIC OCULAR DEVICES | TRANSITIONS OPTICAL INC (US) | 2008-07-02 | — | — | EP | claimed |
| JP-2007524857-A | — | — | 2007-08-30 | — | — | JP | claimed |
| US-20070113587-A1 | Photochromic ocular devices | TRANSITIONS OPTICAL LIMITED (IE) | 2007-05-24 | — | — | US | claimed |
| EP-1604231-A1 | PHOTOCHROMIC OCULAR DEVICES | TRANSITIONS OPTICAL, INC. (US) | 2005-12-14 | — | — | EP | claimed |
| WO-2004086103-A1 | PHOTOCHROMIC OCULAR DEVICES | TRANSITIONS OPTICAL INC. (US) | 2004-10-07 | — | — | WO | claimed |
| US-20040186241-A1 | Photochromic ocular devices | TRANSITIONS OPTICAL, INC. | 2004-09-23 | — | — | US | claimed |
| EP-0131468-B1 | ULTRAVIOLET ABSORBING POLYMERS COMPRISING 2-HYDROXY-5-ACRYLYLOXALKYLPHENYL-2H-BENZOTRIAZOLES | IOLAB CORPORATION (US) | 1990-01-17 | — | — | EP | claimed |
| US-4528311-A | Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles | IOLAB CORPORATION (US) | 1985-07-09 | — | — | US | claimed |
| EP-0131468-A2 | Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxalkylphenyl-2H-benzotriazoles | IOLAB CORPORATION (US) | 1985-01-16 | — | — | EP | claimed |
| US-20260022221-A1 | LAMINATE AND RESIN MOLDED BODY CONTAINING SAME | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| US-12479194-B2 | Laminate | TOYOBO CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-4889664-A | MOLDING HYDROPHILIC (METH)ACRYLATE ESTER AND WATER DISPLACABLE BORIC ACID ESTER DILUENT | VISTAKON, INC. (US) | 1989-12-26 | — | — | US | disclosed |
| EP-0131468-A2 | Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxalkylphenyl-2H-benzotriazoles | IOLAB CORPORATION (US) | 1985-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022221-A1 | LAMINATE AND RESIN MOLDED BODY CONTAINING SAME | MAP1LC3C, MAP1LC3B, MAP1LC3A | LMNA 40/4885NPC1 3951/4885RAB9A 1988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.